The worldwide Personalized Genomics Market stood at USD 7.97 Billion in 2022, and is expected to reach USD 32.15 Billion by 2031, recording a CAGR of 16.96% from 2023 through 2031.
At its core, Personalized Genomics pertains to landscape are risingly turning to these solutions to meet contemporary demands.
Market momentum is bolstered by rising appetite for advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, bolstered by rapid industrialization and expanding end-user bases.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Personalized Genomics Market Snapshot
Chapter 4. Global Personalized Genomics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Test Type Estimates & Trend Analysis
5.1. By Test Type, & Market Share, 2019 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 for the following By Test Type:
5.2.1. Oncology Testing
5.2.2. Infectious Disease Testing
5.2.3. Neurological Testing
5.2.4. Cardiovascular Testing
5.2.5. Others
Chapter 6. Market Segmentation 2: By Technology Estimates & Trend Analysis
6.1. By Technology & Market Share, 2019 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 for the following By Technology:
6.2.1. PCR-based Tests
6.2.2. Microarray-based Tests
6.2.3. Sequencing-based Tests
6.2.4. Others
Chapter 7. Market Segmentation 3: By Application Estimates & Trend Analysis
7.1. By Application & Market Share, 2019 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 for the following By Application:
7.2.1. Diagnostics
7.2.2. Precision Medicine
7.2.3. Wellness
7.2.4. Reproductive Health
7.2.5. Sports Nutrition & Health Lifestyle
7.2.6. Others
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. By End User & Market Share, 2019 & 2031
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 for the following By End User:
8.2.1. Hospitals & Clinics
8.2.2. Research Centers
8.2.3. Pharmaceutical & Biotechnology Companies
8.2.4. Diagnostic Laboratories,
8.2.5. Others
Chapter 9. Personalized Genomics Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Personalized Genomics Market revenue (US$ Million) estimates and forecasts By Test Type, 2023- 2031
9.1.2. North America Personalized Genomics Market revenue (US$ Million) estimates and forecasts By Technology, 2023- 2031
9.1.3. North America Personalized Genomics Market revenue (US$ Million) estimates and forecasts By Application, 2023- 2031
9.1.4. North America Personalized Genomics Market revenue (US$ Million) estimates and forecasts By End User, 2023- 2031
9.1.5. North America Personalized Genomics Market revenue (US$ Million) estimates and forecasts by country, 2023- 2031
9.2. Europe
9.2.1. Europe Personalized Genomics Market revenue (US$ Million) By Test Type, 2023- 2031
9.2.2. Europe Personalized Genomics Market revenue (US$ Million) By Technology, 2023- 2031
9.2.3. Europe Personalized Genomics Market revenue (US$ Million) By Application, 2023- 2031
9.2.4. Europe Personalized Genomics Market revenue (US$ Million) By End User, 2023- 2031
9.2.5. Europe Personalized Genomics Market revenue (US$ Million) by country, 2023- 2031
9.3. Asia Pacific
9.3.1. Asia Pacific Personalized Genomics Market revenue (US$ Million) By Test Type, 2023- 2031
9.3.2. Asia Pacific Personalized Genomics Market revenue (US$ Million) By Technology, 2023- 2031
9.3.3. Asia Pacific Personalized Genomics Market revenue (US$ Million) By Application, 2023- 2031
9.3.4. Asia Pacific Personalized Genomics Market revenue (US$ Million) By End User, 2023- 2031
9.3.5. Asia Pacific Personalized Genomics Market revenue (US$ Million) by country, 2023- 2031
9.4. Latin America
9.4.1. Latin America Personalized Genomics Market revenue (US$ Million) By Test Type, (US$ Million) 2023- 2031
9.4.2. Latin America Personalized Genomics Market revenue (US$ Million) By Technology, (US$ Million) 2023- 2031
9.4.3. Latin America Personalized Genomics Market revenue (US$ Million) By Application, (US$ Million) 2023- 2031
9.4.4. Latin America Personalized Genomics Market revenue (US$ Million) By End User, (US$ Million) 2023- 2031
9.4.5. Latin America Personalized Genomics Market revenue (US$ Million) by country, 2023- 2031
9.5. Middle East & Africa
9.5.1. Middle East & Africa Personalized Genomics Market revenue (US$ Million) By Test Type, (US$ Million) 2023- 2031
9.5.2. Middle East & Africa Personalized Genomics Market revenue (US$ Million) By Technology, (US$ Million) 2023- 2031
9.5.3. Middle East & Africa Personalized Genomics Market revenue (US$ Million) By Application (US$ Million) 2023- 2031
9.5.4. Middle East & Africa Personalized Genomics Market revenue (US$ Million) By End User, (US$ Million) 2023- 2031
9.5.5. Middle East & Africa Personalized Genomics Market revenue (US$ Million) by country, 2023- 2031
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. 23andMe,
10.2.2. Mapmygenome,
10.2.3. Invitea,
10.2.4. Genetic Technology Limited,
10.2.5. Lonza,
10.2.6. Interleukin Genetics, Inc,
10.2.7. GNA Genotek,
10.2.8. Helix,
10.2.9. MyHeritage,
10.2.10. Pathway Genomics,
10.2.11. Veritas Genetics,
10.2.12. Xcode,
10.2.13. Color Genomics,
10.2.14. Myriad Genetics,
10.2.15. Quest Diagnostics,
10.2.16. Bio-Rad Laboratories, Inc.,
10.2.17. Illumina,
10.2.18. Thermo Fisher Scientific,
10.2.19. Qiagen,
10.2.20. Genomic Health,
10.2.21. Nebula Genomics
10.2.22. Eastern Biotech and Life Sciences,
10.2.23. uBiome, Inc